Daewon Pharmaceutical said Thursday that padoprazan (DW4421), its investigational treatment for gastroesophageal reflux ...

GC Biopharma and Hanmi Pharmaceutical said Friday they have signed an exclusive licensing agreement with BioMarin ...

Korea will expand health insurance coverage for five drugs for rare, hard-to-treat diseases next month, extending Crysvita ...

For Professor Chang Dong-gune, an orthopedic surgeon at Yeouido St. Mary's Hospital, treating spinal disease increasingly ...

GC Biopharma said Friday it received approval from the Ministry of Food and Drug Safety (MFDS) for Hunterase ICV (idursulfase ...

The number of counties in Korea without an obstetrician-gynecologist could nearly triple from nine in 2025 to 25 by 2035, ...

Global pharmaceutical companies increased their clinical research spending in Korea by 5.3 percent to 1.09 trillion won ($819 ...

The Supreme Court has overturned a lower court ruling upholding a pediatrician's license suspension for administering a ...

Hanlim Pharmaceutical has signed a memorandum of understanding (MOU) with Japanese venture capital firm DCI Partners to ...

NEX-I plans to pursue global licensing deals for its immuno-oncology and antibody-drug conjugate (ADC) candidates following ...

Samjin Pharmaceutical's Lorazepam Injection, an emergency medicine used to stop prolonged seizures, including potentially ...

KAIST researchers developed an antibody candidate that restored food intake. They improved body weight and muscle strength in ...